These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 1655915

  • 21. Synthesis and biological activity of a fluorescent analogue of 2-5A.
    Lesiak K, Torrence PF.
    FEBS Lett; 1983 Jan 24; 151(2):291-6. PubMed ID: 6832358
    [No Abstract] [Full Text] [Related]

  • 22. Antiviral activity of a chemically stabilized 2-5A analog upon microinjection into HeLa cells.
    Defilippi P, Huez G, Verhaegen-Lawalle M, De Clercq E, Imai J, Torrence P, Content J.
    FEBS Lett; 1986 Mar 31; 198(2):326-32. PubMed ID: 2420642
    [Abstract] [Full Text] [Related]

  • 23. Inhibition of topoisomerase I by antibodies in sera from scleroderma patients.
    Samuels DS, Tojo T, Homma M, Shimizu N.
    FEBS Lett; 1986 Dec 15; 209(2):231-4. PubMed ID: 2431927
    [Abstract] [Full Text] [Related]

  • 24. Synthesis and characterization of chimeric 2-5A-DNA oligonucleotides.
    Player MR, Torrence PF.
    Curr Protoc Nucleic Acid Chem; 2001 May 15; Chapter 4():Unit 4.4. PubMed ID: 18428851
    [Abstract] [Full Text] [Related]

  • 25. 2-5A-dependent endoribonuclease activity and effects of A2'p5'A2'p5'A (2-5A core) in mouse pancreatic islets.
    Rhodes CJ, Taylor KW.
    FEBS Lett; 1985 Jan 21; 180(1):69-73. PubMed ID: 3881279
    [Abstract] [Full Text] [Related]

  • 26. Antiviral effects of 2',5'oligoadenylates (2-5As), and related compounds.
    Tominaga A, Saito S, Kohno S, Sakurai K, Hayakawa Y, Noyori R.
    Microbiol Immunol; 1990 Jan 21; 34(9):737-47. PubMed ID: 2178211
    [Abstract] [Full Text] [Related]

  • 27. Synthesis of double-headed 2-5A-antisense chimeras and their ability to activate human RNase L.
    Ueno Y, Okatani S, Yamada Y, Kitade Y.
    Bioorg Med Chem Lett; 2003 Nov 17; 13(22):3959-61. PubMed ID: 14592484
    [Abstract] [Full Text] [Related]

  • 28. Initiation of DNA synthesis by oligoribonucleotides.
    Feix G.
    Basic Life Sci; 1973 Nov 17; 1():301-9. PubMed ID: 4797928
    [No Abstract] [Full Text] [Related]

  • 29. [Effect of camptothecin on the DNA-relaxing and DNA-cleavage activity of calf thymus topoisomerase I].
    Bronshteĭn IB, Gromova II, Bukhman VL, Kafiani KA.
    Mol Biol (Mosk); 1989 Nov 17; 23(2):491-501. PubMed ID: 2549395
    [Abstract] [Full Text] [Related]

  • 30. Histone H1 inhibits eukaryotic DNA topoisomerase I.
    Richter A, Kapitza M.
    FEBS Lett; 1991 Dec 02; 294(1-2):125-8. PubMed ID: 1660406
    [Abstract] [Full Text] [Related]

  • 31. Inhibitory effects of diadenosine polyphosphates and diguanosine polyphosphates on terminal deoxynucleotidyltransferase from calf thymus.
    Ono K, Iwata Y, Nakane H.
    Biomed Pharmacother; 1982 Dec 02; 36(10):414-9. PubMed ID: 7184513
    [Abstract] [Full Text] [Related]

  • 32. [Substance 2-5A--a newly discovered inhibitor of proteosynthesis].
    Vilcek S, Sangret M, Vrtiak OJ, Gdovinová A.
    Cesk Farm; 1982 Dec 02; 31(10):377-83. PubMed ID: 7151188
    [No Abstract] [Full Text] [Related]

  • 33. Synthesis and properties of 5'-triphosphoryl 2'-5' oligoadenylates (2-5A), and a general method for synthesis of 3', 5'-bisphosphorylated oligonucleotides.
    Ikehara M, Oshie K, Hasegawa A, Ohtsuka E.
    Nucleic Acids Res; 1981 Apr 24; 9(8):2003-20. PubMed ID: 7243596
    [Abstract] [Full Text] [Related]

  • 34. Phosphorylation sites for type N II protein kinase in DNA-topoisomerase I from calf thymus.
    Coderoni S, Paparelli M, Gianfranceschi GL.
    Int J Biochem; 1990 Apr 24; 22(7):737-46. PubMed ID: 2169438
    [Abstract] [Full Text] [Related]

  • 35. Purification and characterization of a type I DNA topoisomerase from calf thymus mitochondria.
    Lazarus GM, Henrich JP, Kelly WG, Schmitz SA, Castora FJ.
    Biochemistry; 1987 Sep 22; 26(19):6195-203. PubMed ID: 2825774
    [Abstract] [Full Text] [Related]

  • 36. Isoaurostatin, a novel topoisomerase inhibitor produced by Thermomonospora alba.
    Suzuki K, Yahara S, Maehata K, Uyeda M.
    J Nat Prod; 2001 Feb 22; 64(2):204-7. PubMed ID: 11430001
    [Abstract] [Full Text] [Related]

  • 37. Novel and specific inhibitors of a poxvirus type I topoisomerase.
    Bond A, Reichert Z, Stivers JT.
    Mol Pharmacol; 2006 Feb 22; 69(2):547-57. PubMed ID: 16267207
    [Abstract] [Full Text] [Related]

  • 38. [The effect of 2',5'-oligoadenylates on the expression of the cellular proto-oncogene c-myc during the development of Svec's leukemia in rats].
    Prima VI, Kvitnitskaia AB, Glushakova LG, Tarasenko PD, Stogniĭ AB, Seniuk OF, Platonov OM.
    Tsitol Genet; 1995 Feb 22; 29(6):8-13. PubMed ID: 8713835
    [Abstract] [Full Text] [Related]

  • 39. A high-throughput fluorescence anisotropy-based assay for human topoisomerase II β-catalyzed ATP-dependent supercoiled DNA relaxation.
    Shapiro AB, Austin CA.
    Anal Biochem; 2014 Mar 01; 448():23-9. PubMed ID: 24309019
    [Abstract] [Full Text] [Related]

  • 40. Controlling gene expression with 2-5A antisense.
    Leaman DW, Cramer H.
    Methods; 1999 Jul 01; 18(3):252-65. PubMed ID: 10454983
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.